The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Bioequivalence and the immunogenicity of biopharmaceuticals
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.-J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011931 · Cited by 1,246
Olsen, E., Duvic, M., Frankel, A., Kim, Y., Martin, A., Vonderheid, E., Jegasothy, B., Wood, G., Gordon, M., Heald, P., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.376 · Cited by 609
Cleland, J. L., Powell, M., & Shire, S. J. (1993) · PubMed · Cited by 543
Immunogenicity and Allergenic Potential of Animal and Human Insulins
Schernthaner, G. (1993) · Diabetes Care · doi:10.2337/diacare.16.3.155 · Cited by 247
Ross, C., Clemmesen, K. M., Svenson, M., S�rensen, P. S., Koch‐Henriksen, N., Skovgaard, G. L., Bendtzen, K., & the Danish Multiple Sclerosis Study Group (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<706::aid-ana3>3.0.co;2-v · Cited by 240
Role of Aggregated Human Growth Hormone (hGH) in Development of Antibodies to hGH*
MOORE, W. V., & LEPPERT, P. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-4-691 · Cited by 220
Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF
Gribben, J. G., Devereux, S., Thomas, N. S. B., Keim, M., Jones, H. M., Goldstone, A. H., & Linch, D. C. (1990) · The Lancet · doi:10.1016/0140-6736(90)90665-r · Cited by 210
Rosendaal, F., Nieuwenhuis, H., van den Berg, H., Heijboer, H., Mauser- Bunschoten, E., van der Meer, J., Smit, C., Strengers, P., & Briet, E. (1993) · Blood · doi:10.1182/blood.v81.8.2180.2180 · Cited by 194
Prescott, R., Nakai, H., Saenko, E. L., Scharrer, I., Nilsson, I. M., Humphries, J. E., Hurst, D., Bray, G., Scandella, D., & Groups, T. R. A. K. S. (1997) · Blood · doi:10.1182/blood.v89.10.3663 · Cited by 183
Construction and Characterization of a Lipotes vexillifer Genomic DNA BAC Library
Du, B. X., Zhang, X., Fang, S., & Wang, D. (2007) · ZOOLOGICAL SCIENCE · doi:10.2108/zsj.24.401 · Cited by 125
Antibodies to recombinant human erythropoietin causing pure red cell aplasia.
Ss, P., & Muhlfelder, T. W. (1997) · PubMed · Cited by 116
The structure of human interferon- ? : implications for activity
Karpusas, M., Whitty, A., Runkel, L., & Hochman, P. S. (1998) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050248 · Cited by 113
Chaffee, S., Mary, A., Stiehm, E. R., Girault, D., Fischer, A., & Hershfield, M. S. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115761 · Cited by 111
Ottesen, J. L., Nilsson, P., Jami, J., Weilguny, D., D�hrkop, M., Bucchini, D., Havelund, S., & Fogh, J. M. (1994) · Diabetologia · doi:10.1007/bf00399790 · Cited by 107
de Perini, P., Facchinetti, A., Bulian, P., Massaro, A. R., de Pascalis, D., Bertolotto, A., Biasi, G., & Gallo, P. (2001) · PubMed · Cited by 94
Immunogenicity of biopharmaceuticals in laboratory animals
Wierda, D., Smith, H. W., & Zwickl, C. M. (2001) · Toxicology · doi:10.1016/s0300-483x(00)00410-8 · Cited by 76
The immunogenicity of insulin preparations.
Chance, R. E., Root, M. A., & Galloway, J. A. (1976) · PubMed · Cited by 75
Gilles, J. G., Jacquemin, M. G., & Saint-Remy, J.-M. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657604 · Cited by 73
LEVY, F., Muff, R., Dotti-Sigrist, S., Dambacher, M. A., & Ja, F. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-541 · Cited by 71
Clinical investigation of the immunogenicity of interferon-alpha 2a.
Ryff, J. ‐. (1997) · PubMed · Cited by 67
Immunoregulation and blocking antibodies induced by interferon beta treatment in MS
Zang, Y. C. Q., Yang, D., Hong, J., Tejada-Simon, M. V., Rivera, V. M., & Zhang, J. Z. (2000) · Neurology · doi:10.1212/wnl.55.3.397 · Cited by 58
‘Biogenerics’: the off-patent biotech products
Schellekens, H., & Ryff, J. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01967-2 · Cited by 56
Self-citationCorrelation between Factor VIII Genotype and Inhibitor Development in Hemophilia A
Fakharzadeh, S. S., & Kazazian, H. H. (2000) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2000-9819 · Cited by 55
Zwickl, C. M. (1991) · Fundamental and Applied Toxicology · doi:10.1016/0272-0590(91)90112-h · Cited by 48
Treatment-induced antibodies to interleukin-2
Prümmer, O. (1997) · Biotherapy · doi:10.1007/bf02678213 · Cited by 46
Schernthaner, G., Borkenstein, M., Fink, M. K., Mayr, W. R., Menzel, J., & Schober, E. (1983) · PubMed · Cited by 46
Immunogenicity of intraperitoneal insulin infusion using programmable implantable devices
Jeandidier, N., Boivin, S., Sapin, R., Rosart-Ortega, F., Uring‐Lambert, B., R�ville, P., & Pinget, M. (1995) · Diabetologia · doi:10.1007/bf00400727 · Cited by 45
Ta, S., Hollingshead, P. G., Sl, P., Chang, R., Martin, L. E., & Oakley, H. (1989) · PubMed · Cited by 42
Eisenberg, J. D., Aitken, M. L., Dorkin, H. L., Harwood, I. R., Ramsey, B. W., Schidlow, D. V., Wilmott, R. W., Wohl, M. E. B., Fuchs, H. J., Christiansen, D. H., et al. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70134-3 · Cited by 36
Analysing structure-function relationships with biosensors
Regenmortel, M. H. V. V. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000900 · Cited by 32
Blumenfeld, Z., Frisch, L., & Conn, P. M. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60195-4 · Cited by 32
Randolph, J. F., Stokol, T., Scarlett, J. M., & MacLeod, J. N. (1999) · American Journal of Veterinary Research · doi:10.2460/ajvr.1999.60.05.636 · Cited by 24
Immunogenicity of interferon-alpha 2 in therapy: structural and physiological aspects.
KONTSEK, P., Liptáková, H., & Kontseková, E. (1999) · PubMed · Cited by 21
Interferon antibodies in patients with infectious diseases
Antonelli, G., Simeoni, E., Currenti, M., Pisa, F. D., Colizzi, V., Pistello, M., & DIANZANI, F. (1997) · Biotherapy · doi:10.1007/bf02678212 · Cited by 16
Interferon antibodies in patients with infectious diseases
Antonelli, G., Simeoni, E., Currenti, M., Pisa, F. D., Colizzi, V., Pistello, M., & DIANZANI, F. (1997) · Springer eBooks · doi:10.1007/978-94-011-5664-6_2 · Cited by 9
Towards a Quantitative Model of Immunogenicity: Counting Pathways in Sequence Space
Chang, T. Y. (2000) · Journal of Theoretical Biology · doi:10.1006/jtbi.2000.2122 · Cited by 4
Cited by
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
Filipe, V., Hawe, A., & Jiskoot, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0073-2 · Cited by 1,885
Structure-Immunogenicity Relationships of Therapeutic Proteins
Hermeling, S., Crommelin, D. J. A., Schellekens, H., & Jiskoot, W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029275.41323.a6 · Cited by 617
Self-citationChen, B.-M., Cheng, T.-L., & Roffler, S. R. (2021) · ACS Nano · doi:10.1021/acsnano.1c05922 · Cited by 563
Immunogenicity of therapeutic proteins: Clinical implications and future prospects
Schellekens, H. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)80075-3 · Cited by 556
Self-citation
Metadata
- Authors
- Schellekens, H.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-06
- Volume
- 1
- Issue
- 6
- Pages
- 457-462
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1979325667
- Cited by
- 534
- References
- 36
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.